Immediate Impact
17 standout
Citing Papers
New clinical trial design in precision medicine: discovery, development and direction
2024 Standout
Towards targeting the breast cancer immune microenvironment
2024 Standout
Works of Heejung Chae being referenced
Response Rate and Safety of a Neoadjuvant Pertuzumab, Atezolizumab, Docetaxel, and Trastuzumab Regimen for Patients With ERBB2-Positive Stage II/III Breast Cancer
2022
Therapeutic relevance of targeted sequencing in management of patients with advanced biliary tract cancer: DNA damage repair gene mutations as a predictive biomarker
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Heejung Chae | 161 | 73 | 50 | 74 | 41 | 241 | |
| W Schmiegel | 114 | 61 | 44 | 69 | 25 | 281 | |
| Orhun Çığ Taşkın | 121 | 63 | 25 | 94 | 33 | 234 | |
| Valeria Denninghoff | 90 | 63 | 61 | 57 | 31 | 236 | |
| E. Lévy | 119 | 70 | 24 | 52 | 32 | 269 | |
| Naóe Kinoshita | 85 | 82 | 34 | 131 | 48 | 252 | |
| Shagufta Shaheen | 105 | 44 | 27 | 33 | 31 | 219 | |
| Cristina Iosif | 94 | 77 | 45 | 73 | 33 | 262 | |
| Nae Yu Kim | 97 | 93 | 42 | 68 | 42 | 279 | |
| Erika Hissong | 114 | 71 | 52 | 88 | 38 | 291 | |
| Toshiko Yamochi | 181 | 63 | 28 | 41 | 37 | 282 |
All Works
Login with ORCID to disown or claim papers
Loading papers...